RxNorm Names
Not yet provided
SYREFLUX
(penicillium roqueforti)
tablet
[Syntrion GmbH]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bfbb1609-7e04-4e55-b7bb-6e2368ebe226| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | unapproved homeopathic |
NOTE:THIS HOMEOPATHIC PRODUCT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION FOR SAFETY OR EFFICACY. FDA IS NOT AWARE OF SCIENTIFIC EVIDENCE TO SUPPORT HOMEOPATHY AS EFFECTIVE.
| SYREFLUX
penicillium roqueforti tablet |
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
| Labeler - Syntrion GmbH (331883145) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Spreewälder Arzneimittel GmbH | 332313084 | MANUFACTURE(10424-167) | |
Revised: 02/2013
Document Id: 7dd943ca-5f5a-4a98-87b5-4dc66ef8a56f
Set id: bfbb1609-7e04-4e55-b7bb-6e2368ebe226
Version: 1
Effective Time: 20130204
Syntrion GmbH
